Haier Biomedical repurchases shares for employee incentive plans

Qingdao Haier Biomedical Co., Ltd. has announced the progress of its share repurchase program via centralized bidding transactions. As of August 31, 2025, the company has cumulatively repurchased 2,376,245 shares, representing 0.7474% of its total share capital. The total expenditure for these repurchases amounts to 77,120,896.36 yuan (excluding transaction fees).

The repurchases were executed within a price range of 29.86 yuan per share to 34.69 yuan per share. The company's repurchase scheme, initiated on January 14, 2025, intends to utilize the repurchased shares for employee stock ownership plans or equity incentives, with a total value ranging from 100 million yuan to 200 million yuan.

Following an adjustment due to the 2024 annual equity distribution, the maximum repurchase price was set at 49.5367 yuan per share, effective June 6, 2025. The repurchase period extends for 12 months from the approval date of the scheme. Qingdao Haier Biomedical commits to adhering to relevant regulations and will continue to make repurchases and disclose progress accordingly.